Clinical trials
Leukemia, B-Cell trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 7 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Leon Berard | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| Innovative Cellular Therapeutics Co., Ltd. | 1 |
| Kang YU | 1 |
| Ossium Health, Inc. | 1 |
| Private Hospital of Confluent, France | 1 |
| Qingdao Central Hospital | 1 |
| Shenzhen Geno-Immune Medical Institute | 1 |
| Technical University of Munich | 1 |
| University Hospital, Toulouse | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, B-Cell | 12 |
| Lymphoma, B-Cell | 4 |
| Leukemia | 3 |
| Lymphoma | 3 |
| Hodgkin Disease | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, T-Cell | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Adrenoleukodystrophy | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.